Panbela Therapeutics Inc

NASDAQ:PBLA  
1.51
-0.05 (-3.20%)
Earnings Announcements

Panbela Provides Business Update And Reports Q4 And FY 2021 Financial Results

Published: 03/24/2022 20:54 GMT
Panbela Therapeutics Inc (PBLA) - Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results.
Q4 Loss per Share $0.26.
Revenue is expected to be $-0.11 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $-0.12 Million
Next Quarter EPS Guidance is expected to be -$0.23

More details on our Analysts Page.